Frankfurt - Delayed Quote EUR

Akebia Therapeutics, Inc. (AX9.F)

Compare
2.1640
+0.0080
+(0.37%)
At close: January 29 at 8:06:58 AM GMT+1

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
ADAMS ADRIAN Director Stock Award(Grant) Jun 6, 2024 164,800
DAHAN MICHEL Chief Operating Officer Sale May 13, 2024 672,092
FRIESON RON Director Conversion of Exercise of derivative security Jan 17, 2025 93,800
GILMAN STEVEN C Director Stock Award(Grant) Jun 6, 2024 117,130
HADAS NICOLE R Officer Sale May 13, 2024 651,243
OSTROWSKI ERIK Chief Financial Officer Stock Award(Grant) Jun 28, 2024 350,000
ROGERS MICHAEL W Director Stock Award(Grant) Jun 6, 2024 126,029
SMITH CYNTHIA Director Stock Award(Grant) Jun 6, 2024 125,233
WOLF MYLES Director Stock Award(Grant) Jun 6, 2024 97,681
ZUMWALT LEANNE M Director Stock Award(Grant) Jun 6, 2024 73,700

Related Tickers